27502245|t|Cartilage inflammation and degeneration is enhanced by pro-inflammatory (M1) macrophages in vitro, but not inhibited directly by anti-inflammatory (M2) macrophages
27502245|a|Macrophages play a crucial role in the progression of osteoarthritis (OA). Their phenotype may range from pro-inflammatory to anti-inflammatory. The aim of this study was to evaluate the direct effects of macrophage subtypes on cartilage by culturing macrophage conditioned medium (MCM) on human articular cartilage. Human OA cartilage explants were cultured with MCM of pro-inflammatory M (IFNγ + TNFα), or anti-inflammatory M (IL-4) or M (IL-10) human monocyte-derived macrophages. To assess effects of anti-inflammatory macrophages, the cartilage was cultured with a combination of MCM phenotypes as well as pre-stimulated with IFNγ + TNFα cartilage before culture with MCM. The reactions of the explants were assessed by gene expression, nitric oxide (NO) production and release of glycosaminoglycans (GAGs). M (IFNγ + TNFα) MCM affected OA cartilage by upregulation of IL1B (Interleukin 1β), IL6, MMP13 (Matrix Metalloproteinase-13) and ADAMTS5 (A Disintegrin And Metalloproteinase with Thrombospondin Motifs-5), while inhibiting ACAN (aggrecan) and COL2A1 (collagen type II). M (IL-10) upregulated IL1B and Suppressor of cytokine signaling 1 (SOCS1). NO production and GAG release by the cartilage was increased when cultured with M (IFNγ + TNFα) MCM. M (IL-4) and M (IL-10) did not inhibit the effects of M (IFNγ + TNFα) MCM of neither phenotype affected IFNγ + TNFα pre-stimulated cartilage, in which an inflammatory gene response was deliberately induced. M (IFNγ + TNFα) macrophages have a prominent direct effect on OA cartilage, while M (IL-4) and M (IL-10) do not inhibit the effects of M (IFNγ + TNFα), or IFN γ+ TNFα induced inflammation of the cartilage. Therapies aiming at inhibiting cartilage degeneration may take this into account by directing suppression of pro-inflammatory macrophages or stimulation of anti-inflammatory macrophages.
27502245	0	22	Cartilage inflammation	T038	UMLS:C0008439
27502245	27	39	degeneration	T038	UMLS:C1285228
27502245	72	88	(M1) macrophages	T017	UMLS:C0024432
27502245	147	163	(M2) macrophages	T017	UMLS:C4086555
27502245	164	175	Macrophages	T017	UMLS:C0024432
27502245	218	232	osteoarthritis	T038	UMLS:C0029408
27502245	234	236	OA	T038	UMLS:C0029408
27502245	369	379	macrophage	T017	UMLS:C0024432
27502245	380	388	subtypes	T170	UMLS:C0449560
27502245	392	401	cartilage	T017	UMLS:C0007301
27502245	405	414	culturing	T058	UMLS:C0430400
27502245	415	425	macrophage	T017	UMLS:C0024432
27502245	426	444	conditioned medium	T103	UMLS:C0162518
27502245	446	449	MCM	T103	UMLS:C0162518
27502245	454	459	human	T204	UMLS:C0086418
27502245	460	479	articular cartilage	T017	UMLS:C0007303
27502245	481	486	Human	T204	UMLS:C0086418
27502245	487	489	OA	T038	UMLS:C0029408
27502245	490	499	cartilage	T017	UMLS:C0007301
27502245	500	508	explants	T058	UMLS:C0444933
27502245	514	522	cultured	T058	UMLS:C0430400
27502245	528	531	MCM	T103	UMLS:C0162518
27502245	535	553	pro-inflammatory M	T017	UMLS:C0024432
27502245	555	559	IFNγ	T103	UMLS:C0021745
27502245	562	566	TNFα	T103	UMLS:C1456820
27502245	572	591	anti-inflammatory M	T017	UMLS:C0024432
27502245	593	598	IL-4)	T103	UMLS:C0021758
27502245	602	603	M	T017	UMLS:C0024432
27502245	605	610	IL-10	T103	UMLS:C0085295
27502245	612	617	human	T204	UMLS:C0086418
27502245	618	646	monocyte-derived macrophages	T017	UMLS:C0024432
27502245	669	698	anti-inflammatory macrophages	T017	UMLS:C0024432
27502245	704	713	cartilage	T017	UMLS:C0007301
27502245	718	726	cultured	T058	UMLS:C0430400
27502245	749	752	MCM	T103	UMLS:C0162518
27502245	795	799	IFNγ	T103	UMLS:C0021745
27502245	802	806	TNFα	T103	UMLS:C1456820
27502245	807	816	cartilage	T017	UMLS:C0007301
27502245	824	831	culture	T058	UMLS:C0430400
27502245	837	840	MCM	T103	UMLS:C0162518
27502245	889	904	gene expression	T038	UMLS:C0017262
27502245	906	934	nitric oxide (NO) production	T038	UMLS:C3155545
27502245	950	968	glycosaminoglycans	T103	UMLS:C0017973
27502245	970	974	GAGs	T103	UMLS:C0017973
27502245	977	978	M	T017	UMLS:C0024432
27502245	980	984	IFNγ	T103	UMLS:C0021745
27502245	987	991	TNFα	T103	UMLS:C1456820
27502245	993	996	MCM	T103	UMLS:C0162518
27502245	1006	1008	OA	T038	UMLS:C0029408
27502245	1009	1018	cartilage	T017	UMLS:C0007301
27502245	1022	1034	upregulation	T038	UMLS:C0041904
27502245	1038	1042	IL1B	T103	UMLS:C0021753
27502245	1044	1058	Interleukin 1β	T103	UMLS:C0021753
27502245	1061	1064	IL6	T103	UMLS:C0021760
27502245	1066	1071	MMP13	T103	UMLS:C0255672
27502245	1073	1100	Matrix Metalloproteinase-13	T103	UMLS:C0255672
27502245	1106	1113	ADAMTS5	T103	UMLS:C4255122
27502245	1115	1179	A Disintegrin And Metalloproteinase with Thrombospondin Motifs-5	T103	UMLS:C4255122
27502245	1199	1203	ACAN	T103	UMLS:C1429453
27502245	1205	1213	aggrecan	T103	UMLS:C1429453
27502245	1219	1225	COL2A1	T103	UMLS:C1505419
27502245	1227	1243	collagen type II	T103	UMLS:C1505419
27502245	1246	1247	M	T017	UMLS:C0024432
27502245	1249	1254	IL-10	T103	UMLS:C0085295
27502245	1256	1267	upregulated	T038	UMLS:C0041904
27502245	1268	1272	IL1B	T103	UMLS:C0021753
27502245	1277	1311	Suppressor of cytokine signaling 1	T103	UMLS:C3275256
27502245	1313	1318	SOCS1	T103	UMLS:C3275256
27502245	1321	1334	NO production	T038	UMLS:C3155545
27502245	1339	1342	GAG	T103	UMLS:C0017973
27502245	1358	1367	cartilage	T017	UMLS:C0007301
27502245	1387	1395	cultured	T058	UMLS:C0430400
27502245	1401	1402	M	T017	UMLS:C0024432
27502245	1404	1408	IFNγ	T103	UMLS:C0021745
27502245	1411	1415	TNFα	T103	UMLS:C1456820
27502245	1417	1420	MCM	T103	UMLS:C0162518
27502245	1422	1423	M	T017	UMLS:C0024432
27502245	1425	1430	IL-4)	T103	UMLS:C0021758
27502245	1435	1436	M	T017	UMLS:C0024432
27502245	1438	1444	IL-10)	T103	UMLS:C0085295
27502245	1476	1477	M	T017	UMLS:C0024432
27502245	1479	1483	IFNγ	T103	UMLS:C0021745
27502245	1486	1490	TNFα	T103	UMLS:C1456820
27502245	1492	1495	MCM	T103	UMLS:C0162518
27502245	1526	1530	IFNγ	T103	UMLS:C0021745
27502245	1533	1537	TNFα	T103	UMLS:C1456820
27502245	1553	1562	cartilage	T017	UMLS:C0007301
27502245	1576	1593	inflammatory gene	T017	UMLS:C0017337
27502245	1629	1630	M	T017	UMLS:C0024432
27502245	1632	1636	IFNγ	T103	UMLS:C0021745
27502245	1639	1643	TNFα	T103	UMLS:C1456820
27502245	1645	1656	macrophages	T017	UMLS:C0024432
27502245	1691	1693	OA	T038	UMLS:C0029408
27502245	1694	1703	cartilage	T017	UMLS:C0007301
27502245	1711	1712	M	T017	UMLS:C0024432
27502245	1714	1719	IL-4)	T103	UMLS:C0021758
27502245	1724	1725	M	T017	UMLS:C0024432
27502245	1727	1733	IL-10)	T103	UMLS:C0085295
27502245	1764	1765	M	T017	UMLS:C0024432
27502245	1767	1771	IFNγ	T103	UMLS:C0021745
27502245	1774	1778	TNFα	T103	UMLS:C1456820
27502245	1784	1787	IFN	T103	UMLS:C0021745
27502245	1791	1795	TNFα	T103	UMLS:C1456820
27502245	1804	1816	inflammation	T038	UMLS:C0021368
27502245	1824	1833	cartilage	T017	UMLS:C0007301
27502245	1835	1844	Therapies	T058	UMLS:C0087111
27502245	1866	1888	cartilage degeneration	T038	UMLS:C1285228
27502245	1929	1940	suppression	T038	UMLS:C0038855
27502245	1944	1972	pro-inflammatory macrophages	T017	UMLS:C0024432
27502245	1991	2020	anti-inflammatory macrophages	T017	UMLS:C0024432